Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

INTERIM METHODS FOR DEVELOPMENT OF INHALATION REFERENCE CONCENTRATIONS

On this page:

  • Overview
  • Downloads

Alert
Alert Notice - This site contains archived material(s)

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact us form if you need additional support.

Abstract

An inhalation reference concentration (RfC) is an estimate of continuous inhalation exposure over a human lifetime that is unlikely to pose significant risk of adverse noncancer health effects and serves as a benchmark value for assisting in risk managmement decisions. erivation of an RfC involves dose-response assessment of animal data to determine the exposure levels at which no significant increase in the frequency or severity of adverse effects between the exposed population and its appropriate control exists. his assessment requires an interspecies dose extrapolaton from a no-observed-adverse effect level (NOAEL) exposure concentration of an animal to a human equivalent NOAEL (NOAEL). he RfC is derived from the NOAEL by the application of generally order-of-magnitude uncertainty factors. ntermittent exposure scenarios in animals are extrapolated to chronic continuous human exposures. elationships between external exposures and internal doses depend upon complex simultaneous and consecutive processes of absorpton, distributon, metabolism, storage, detoxification, and elimination. o estimate NOAEL when chemical-specific physiologically-based pharmacokinetic models are not available, a dosimetric extrapolation procedure based on anatomical and physiological parameters of the exposed human and animal and the physical parameters of the toxic chemical has been developed which gives equivalent or more conservative exposure concentrations values than those that would be obtained with a PB-PK model.

Citation

Jarabek, A., M. Dourson, AND J. Overton. INTERIM METHODS FOR DEVELOPMENT OF INHALATION REFERENCE CONCENTRATIONS. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/8-90/066A (NTIS PB90238890).

Download(s)

  • INTERIM METHODS FOR DEVELOPMENT OF INHALATION REFERENCE CONCENTRATIONS
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on July 22, 2004
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.